Collects heart tracings and patient views in heart failure care
Collects heart electrical recordings and patient feedback in people with heart failure.
Plain-language title generated from the registry record
Registry title: Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care
Key facts
- Where
- London, United KingdomSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 80 years old?
Source: NCT06809686, who can take part
Where in United Kingdom
- Richmond PharmacologyLondon, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Richmond Research Institute
- Trial code
- NCT06809686
- Record updated
- 20 May 2026
- Original description
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.Read full original descriptionShow less
An Observational Study to Collect High Resolution 12-Lead Electrocardiogram (ECG) Data for the Development of an ECG Library to Support the Development of a Tool to Monitor Disease Progression, Gather Patient Perspectives on Standard of Care Heart Failure Procedures and Facilitate Familiarity With the Clinical Trial Environment in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.
Inclusion: Male or female participants aged 45 to 80 years (inclusive) at the date of signing the informed consent; Diagnosed with heart failure; Able and willing to provide informed consent to participate.
Exclusion: Diagnostic test results positive for:; HIV-1 or HIV-2 infection; Hepatitis B or Hepatitis C infection; Any condition judged by the Investigator to pose an undue risk while participating in the trial; Diagnostic results which are inconsistent with heart failure with mildly reduced or preserved ejection fraction as judged by the Investigator; Mental incapacity, language barriers or unwillingness to comply with the requirements of the protocol, which may preclude adequate understanding or cooperation during the study as judged by the Investigator.